Searched for
USA PHARMACEUTICAL MARKET
$10. 6 billion deal: GSK to buy US cancer specialist NuvalentBritish pharmaceutical giant GSK has announced a massive $10.6 billion deal to acquire Nuvalent. This Boston-based company specializes in c...- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 33%To get clarity on the markets, there are three questions to which you need answers. First: When will the war end? Second: How long will it ...
- Will the currency cycle help them? Yes, but very selectively: 10 pharma stocks with upside potential of up to 33%The biggest mistake made in currency cycles is to confuse revenue gain with pure earnings gain. A company may report stronger rupee revenue...
- Glenmark, Granules, Zydus recall products in US over manufacturing issues: USFDAIndian drugmakers Glenmark, Granules India, Sun Pharma, Zydus, and Unichem are recalling various products in the US market due to manufactu...
- Glenmark acquires Acetylcysteine injection, launches in US marketGlenmark Pharmaceuticals Ltd acquired the generic version of Acetylcysteine injection from Aspen Pharma USA Inc and launched it in the US m...
- Complaint filed against Natco Pharma in US by Fresenius KabiNatco Pharma faces a legal complaint from Fresenius Kabi in the US District Court regarding the marketing of Diazepam injection prefilled s...
- Sun Pharma, Hetero recall drugs in US marketAs per the USFDA, a Class II recall is initiated in a situation in which use of, or exposure to, a violative product may cause temporary or...
- Zydus recalls over 55k bottles of generic drug in USUSFDA said the company is recalling the product due to "failed impurities/ degradation specifications". An out-of-specification (OOS) resul...
- Natco Pharma proposes to acquire Dash PharmaceuticalsAccording to a press release issued by the Hyderabad-based drug maker, Dash is a front-end pharmaceutical sales, marketing and distribution...
- Aurobindo Pharma inks pact to acquire Australian pharma firm's productBased out of Melbourne, Advent Pharmaceuticals is engaged in developing and commercialising generic inhaled medicines for global markets.
- Glenmark gets USFDA nod for skin ointmentGlenmark's current portfolio consists of 113 products authorised for distribution in the US marketplace and approximately 64 ANDA's pending...
- Zydus group firm Nesher Pharmaceuticals gets USFDA nod for a drug"The drug falls in the CNS stimulant segment and is the first product to be developed by the R&D team at Nesher," it added.
- Cadila Healthcare recalls 19,536 bottles of cough treatment drug in USDrug firm Cadila is voluntarily recalling 19,536 bottles of benzonatate capsules, used to treat coughs, in the US due to "wet and/or leakin...
- Cadila Healthcare recalls 15,144 bottles of hypertension drug in USAs per information available on the USFDA website, Zydus Pharmaceuticals USA Inc, the US-based arm of the company, is recalling the drug du...
- Cadila Healthcare recalls blood pressure drug in the USThe recall of the 5,400 bottles has been voluntarily initiated by the company through its US based arm Zydus Pharmaceuticals USA Inc.
- US, EU slowdown may keep pharma export growth at 10%: OfficialThe growth of Indian pharma exports during 2012-13 halved to 10.55% over previous year to $ 14.6 bn. During 2011-12 the exports stood at $ ...
- Glenmark enters into licence, supply pact with Taro PharmaPharma firm Glenmark Pharmaceuticals on Thursday said that it has entered into a licencing agreement with US-based Taro Pharmaceuticals Inc...
Load More
